Dr. Turner's research garners support from esteemed organizations such as Diabetes UK, Marie Skłodowska-Curie Actions, and The Royal Society. His collaborative network spans universities in the UK, Europe, the USA, Canada, and Australia, highlighting a global approach to medical research.
About Dr Mark Turner
Dr. Turner, a distinguished medical researcher, has an extensive background from his PhD in Medicine at the University of Liverpool to postdoctoral studies across prestigious institutions in the USA, including The Scripps Research Institute, Harvard Medical School, and Albert Einstein College of Medicine. Returning to the UK, he's held notable positions at Bart's and The London School of Medicine and Dentistry, and currently at Nottingham Trent University. His editorial contributions include Biochimica Biophysica Acta and Bioscience Reports, with significant governance roles within the Biochemical Society and other esteemed organizations.
Dr. Turner is a renowned keynote speaker, having presented at prestigious conferences like the 8th Annual Biochemistry Symposium in Canada and the OMICS International Conference in the USA. His expertise also led to invitations as a speaker at various international forums, including the Advances in Inflammation and Translational Medicine in London and the FASEB Conference in the USA, covering topics from cellular immunology to systemic autoinflammatory diseases.
About Dr. Turner's Lab
Where Science Meets Innovation
Driven by a passion for unraveling the mysteries of metabolic diseases, Dr. Turner's lab leads the way in groundbreaking research. Our focus on Diabetes, Chronic Diseases & Ageing sets us apart in the field of metabolic medicine.
Drug Discovery Breakthroughs
Exploring new horizons in drug discovery to combat metabolic diseases and revolutionize treatment options.
Advancing Diabetes Research
Leading the way in understanding the intricate relationship between diet, diabetes, and metabolic disorders for improved patient outcomes.
Innovative Antibody Technology
Pioneering research in biochemistry and molecular genetics to understand and treat human diseases at a molecular level.
Multifield
Patents Granted
Numerous High Quality
Publications
Media talked & Media talks
Press expertise
Type 2 diabetes - molecular mechanisms of pancreatic dysfunction,
links to diet, and development of novel treatments
Inflammatory diseases - genetic and cellular defects linked to the
innate immune system
We are in mediaS
https://twitter.com/MDTurnerMedLab/status/1775517635297325385
Voices of Collaboration: What Our Partners and Team Say About Us
"Voices of Collaboration" spotlights testimonials from colleagues and peers in our research lab and their experiences working with Dr. Mark Turner. This section reflects the positive impact of our collaborative efforts and Dr. Turner's leadership in advancing scientific enquiry.
Professor Mark D. Berry
“Over the last few years Dr. Turner and I have established a fruitful, mutually beneficial collaboration that has expanded both of our research portfolios, Dr. Turner in to trace amine-associated receptors and myself in to metabolic disease. I very much look forward to continuing to grow this relationship in to additional areas in future years as we explore new emerging topics of mutual interest.”
Professor and Head, Department of Biochemistry
Dr. Justine-anhua Hu
"Dr. Mark Turner is truly the best and most human supervisor I have encountered during my academic journey. His unwavering honesty, integrity, and genuine commitment to guiding PhD students and postdoctoral researchers stand out. Dr. Turner approaches mentorship with a rare combination of expertise and empathy, always fostering independence while prioritizing the long-term career development of his team members. His exceptional research skills and innovative vision are transformative, driving impactful outcomes. I am excited about the prospect of collaborating further and developing ground-breaking patents under his leadership."
CEO of Life Sciences
Get in touch
Follow us
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.